The generics industry: unlocking new growth drivers
Inside Imexpharm’s EU-GMP–certified pharmaceutical manufacturing plant. Photo: Imexpharm In the final days of 2025, Vietnam’s pharmaceutical sector marked a significant milestone as Imexpharm Corporation introduced its first “first generic” antibiotic – a next-generation product manufactured in compliance with EU-GMP standards. First generic drugs are the earliest generic versions of originator medicines, typically entering the market […]
